(4S)-4-(3-[18F]fluoropropyl-)-L-glutamate
Showing 26 - 50 of >10,000
Tau PET/CT Imaging in Mismatch Prospective Cohort Study
Recruiting
- Alzheimer's Disease
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jan 6, 2023
Adults With Severe Eosinophilic Asthma on Benralizumab.
Active, not recruiting
- Severe Eosinophilic Asthma
- Survey Administration
-
Calgary, Alberta, Canada
- +19 more
Dec 1, 2022
PSMA PET/CT for Assessment of Recurrent Prostate Cancer
Recruiting
- Prostatic Neoplasms
- Prostate Cancer
- PSMA PET/CT scan
-
Vancouver, British Columbia, CanadaBC Cancer
Nov 15, 2021
Multiple Sclerosis Trial in Boston (F-18 3F4AP)
Recruiting
- Multiple Sclerosis
- F-18 3F4AP
-
Boston, MassachusettsMassachusetts General Hospital
May 10, 2021
Breast Cancer Trial in Canada (Diagnostic Imaging: 18F-FDG PET/CT Scan - Baseline, Diagnostic Imaging: 18F-FES PET/CT -
Terminated
- Breast Cancer
- Diagnostic Imaging: 18F-FDG PET/CT Scan - Baseline
- +2 more
-
Kelowna, British Columbia, Canada
- +3 more
Nov 15, 2021
Local Recurrence Following Breast Conserving Surgery and
Active, not recruiting
- Breast Cancer
-
Calgary, Alberta, Canada
- +26 more
Sep 19, 2022
High Risk Neuroblastoma, Recurrent Neuroblastoma, Recurrent Osteosarcoma Trial in Canada, United States (Dinutuximab,
Recruiting
- High Risk Neuroblastoma
- +4 more
- Biospecimen Collection
- +6 more
-
Los Angeles, California
- +10 more
Jan 19, 2023
Vasovagal Syncope Trial in Canada, Poland, United States (midodrine HCl, matching )
Active, not recruiting
- Vasovagal Syncope
- midodrine hydrochloride
- matching placebo
-
Minneapolis, Minnesota
- +16 more
Nov 1, 2022
Prostate Cancer Trial in Hamilton, London, Toronto (18F-DCFPyL PET/CT scan)
Completed
- Prostate Cancer
- 18F-DCFPyL PET/CT scan
-
Hamilton, Ontario, Canada
- +3 more
Mar 24, 2022
Metastatic Tumors Trial in Worldwide (radiation, drug, other)
Recruiting
- Metastatic Tumors
- Palliative Radiation
- +5 more
-
Melbourne, Victoria, Australia
- +13 more
Oct 13, 2022
HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer Trial in Canada (Endocrine therapy may include one of the following
Active, not recruiting
- HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer
- Endocrine therapy may include one of the following therapies: letrozole, anastrozole, exemestane, tamoxifen or fulvestrant
- Endocrine therapy in combination with targeted therapy may include: everolimus plus exemestane or CDK4/6 inhibitor plus endocrine therapy
-
Calgary, Alberta, Canada
- +24 more
Sep 12, 2022
Lung Cancer, Non Small Cell Lung Cancer, NSCLC Stage I Trial in Canada (Selective Targeted Sampling, Systematic Sampling)
Completed
- Lung Cancer
- +3 more
- Selective Targeted Sampling
- Systematic Sampling
-
Edmonton, Alberta, Canada
- +6 more
Jul 25, 2022
Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in Canada (Olaparib, Dasatinib, Nivolumab plus Ipilimumab)
Recruiting
- Lymphoma, Non-Hodgkin
- +2 more
- Olaparib
- +13 more
-
Edmonton, Alberta, Canada
- +9 more
Jan 9, 2023
Mental Health Issue, Hiv, Stigma, Social Trial in Hamilton, Oakville, Toronto (AFFIRM)
Recruiting
- Mental Health Issue
- +3 more
- AFFIRM
-
Hamilton, Ontario, Canada
- +6 more
Oct 31, 2022
Moderate to Severe Opioid Use Disorder Trial in Canada (Extended Release Subcutaneous Buprenorphine, Immediate Release
Not yet recruiting
- Moderate to Severe Opioid Use Disorder
- Extended Release Subcutaneous Buprenorphine
- Immediate Release Sublingual Buprenorphine
-
Barrie, Ontario, Canada
- +4 more
Oct 20, 2022
COVID-19, Coronavirus Infections Trial in Canada (VBI-2901a)
Recruiting
- COVID-19
- Coronavirus Infections
- VBI-2901a
-
Halifax, Nova Scotia, Canada
- +6 more
Nov 16, 2022
Covid19 Trial in Niagara, Toronto, Montreal (Omalizumab, Placebo)
Active, not recruiting
- Covid19
- Omalizumab
- Placebo
-
Niagara, Ontario, Canada
- +2 more
Nov 14, 2022
Hidradenitis Suppurativa Trial in Barrie, Newmarket (Spesolimab Formulation 1, Spesolimab Formulation 2, Placebo matching
Recruiting
- Hidradenitis Suppurativa
- Spesolimab Formulation 1
- +3 more
-
Barrie, Ontario, Canada
- +1 more
Apr 19, 2023
Breast Cancer Trial in Australia, Canada, New Zealand (Ipatasertib, Fulvestrant, Placebo)
Recruiting
- Breast Cancer
- Ipatasertib
- +2 more
-
Bowral, New South Wales, Australia
- +37 more
Aug 8, 2022
Hemophilia, Chronic Disease Trial in Hamilton (Quality of life measure (survey))
Recruiting
- Hemophilia
- Chronic Disease
- Quality of life measure (survey)
-
Hamilton, Ontario, CanadaMcMaster University
Aug 11, 2022
Disease Activity in Canadian Adult Moderate-to-Severe Atopic
Recruiting
- Atopic Dermatitis
-
Calgary, Alberta, Canada
- +17 more
Jan 17, 2023